Loading...
Science 2017-03-14T00:41:08+00:00

RESEARCH APPROACH

Early efforts to develop cannabinoid-based drugs targeted to specific illnesses have faced several challenges. Isolating and synthesizing individual components from the cannabis plant is a complex and complicated process. Cannabinoid compounds’ proportions vary between strains and even individual plants.

HydRx is exploring the properties and treatment applications of the extracts and their drug formulations that leverage the entourage effect of the whole plant. Together, our mission is to create unique phytocannabinoid-based medicines produced to global standards that can be pharmaceutically prescribed for pain relief and other indications.

HydRx has secured unique solutions to all the early stage problems of investigation and product development. Our approach is apply proprietary extraction and processing methods, and create marketable therapies using our innovative and patented delivery systems and technologies.

Applying our R&D expertise in pharmacology, medicinal chemistry and analytical profiling, HydRx plans to produce a wide variety of phytocannabinoid therapies for specific clinical indications.

PIPELINE

HydRx is creating innovations in extraction technologies, drug delivery systems, and novel formulations of cannabinoid compounds for the treatment of:

  1. Neuropathic Pain
  2. Refractory Epilepsy
  3. PTSD
  4. Post-herpetic neuralgia
  5. Alzheimer’s disease
  6. Multiple Sclerosis

HydRx also owns the patent on a unique oral spray (buccal membrane) system for metered delivery of its formulations, and has a topical delivery system for application in preclinical stages. These and other products will be ready for commercialization in 2017.

COLLABORATIONS

Collaborations are an integral part of our strategy at HydRx. We are exploring the broad clinical utility of the endocannabinoid system with multiple academic collaborators. We are developing proprietary tools that should enable us and our collaborators to critically address the roles of the individual molecules within cannabis. We welcome the opportunity to collaborate with companies whose expertise in relevant therapeutic areas will help us develop and commercialize medicines for the patients who need them around the globe.

If you are interested in discussing how we may work together, please use our contact us page or call us at 1-844-HYDRX-CA.